Ceftobiprole regulatory update

Basilea said FDA cancelled a Feb. 28 meeting of its Anti-Infective Drugs Advisory Committee to discuss an NDA for ceftobiprole to treat complicated skin and skin structure infections (cSSSIs). The com...